Source:http://linkedlifedata.com/resource/pubmed/id/15201460
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2004-6-17
|
pubmed:abstractText |
One of the characteristic findings in human Huntington's disease (HD) is the alteration of neurotransmitter receptors. To a remarkable degree, transgenic HD mouse models recapitulate neurotransmitter receptor alterations. Neurotransmitter receptors can be assessed at the protein level by using receptor-binding autoradiography. One can also measure levels of receptor messenger RNA with in situ hybridization (ISH), employing either oligonucleotide or ribonucleotide probes. Both of these techniques-receptor-binding autoradiography and in situ hybridization-yield quantitative and regionally specific information regarding neurotransmitter receptors. We describe techniques for performing receptor-binding autoradiography and two types of in situ hybridization using oligonucleotide and ribonucleotide probes. With receptor binding and ISH, one can obtain quantitative region-specific assessments of neurotransmitter receptor alteration, a key pathologic event in HD pathogenesis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1064-3745
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
277
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
231-60
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15201460-Animals,
pubmed-meshheading:15201460-Autoradiography,
pubmed-meshheading:15201460-Base Sequence,
pubmed-meshheading:15201460-DNA Probes,
pubmed-meshheading:15201460-Humans,
pubmed-meshheading:15201460-Huntington Disease,
pubmed-meshheading:15201460-In Situ Hybridization,
pubmed-meshheading:15201460-Mice,
pubmed-meshheading:15201460-Mice, Transgenic,
pubmed-meshheading:15201460-Receptors, Neurotransmitter
|
pubmed:year |
2004
|
pubmed:articleTitle |
Neurotransmitter receptor analysis in transgenic mouse models.
|
pubmed:affiliation |
Mass General Institute for Neurodegenerative Disease and Department of Neurolofy, Massachusetts General Hospital, Charlestown, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|